To Construct a Prognosis Prediction Model for ECMO Patients Based on Machine Learning Algorithms
1 other identifier
observational
290
1 country
1
Brief Summary
Extracorporeal membrane oxygenation (ECMO) is a critical life-support technique for patients with severe medical conditions. Various factors affect the mortality rates of patients in intensive care units, presenting a significant clinical challenge in accurately predicting outcomes based on a limited set of indicators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
October 9, 2024
CompletedFirst Posted
Study publicly available on registry
October 23, 2024
CompletedOctober 23, 2024
January 1, 2018
6.8 years
October 9, 2024
October 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
survive
Patients were recorded from 48 hours before initiation of ecmo to the date of survival to hospital discharge or death for up to three months
death
Patients were recorded from 48 hours before initiation of ecmo to the date of survival to hospital discharge or death for up to three months
Study Arms (2)
Survive
Death
Eligibility Criteria
The study involved patients who received ECMO treatment at Zhujiang Hospital of Southern Medical University from 2018 to 2024. Exclusion criteria included patients who received ECMO support at outside hospitals and those under the age of 18. Of the patients, 100 were discharged alive, while 190 died during hospitalization.
You may qualify if:
- All patients who underwent ECMO in our hospital and were registered in the CSECLS registry database (ClinicalTrials.gov Identifier:NCT04158479) from January 1, 2018 to now were retrospectively collected.
You may not qualify if:
- ECMO was discontinued for non-medical reasons.
- Under 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510000, China
Related Publications (2)
Ayers B, Wood K, Gosev I, Prasad S. Predicting Survival After Extracorporeal Membrane Oxygenation by Using Machine Learning. Ann Thorac Surg. 2020 Oct;110(4):1193-1200. doi: 10.1016/j.athoracsur.2020.03.128. Epub 2020 May 23.
PMID: 32454016RESULTStephens AF, Seman M, Diehl A, Pilcher D, Barbaro RP, Brodie D, Pellegrino V, Kaye DM, Gregory SD, Hodgson C; Extracorporeal Life Support Organization Member Centres. ECMO PAL: using deep neural networks for survival prediction in venoarterial extracorporeal membrane oxygenation. Intensive Care Med. 2023 Sep;49(9):1090-1099. doi: 10.1007/s00134-023-07157-x. Epub 2023 Aug 7.
PMID: 37548758RESULT
Biospecimen
Observational study without biological samples
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 9, 2024
First Posted
October 23, 2024
Study Start
January 1, 2018
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
October 23, 2024
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share